Agreed, but they shouldn't be running around then saying that this is an "embarrassment of riches" either.
There is certainly no visible signs that they are accomplishing anything. Let's hope that they are doing something behind the scenes with the Technosphere platform.
I certainly agree with your longer term view, but the near term looks pretty rocky.
MNKD is down 13.5%over the same period. Making it way too easy for the shorts. (Of course in the last month or so XBI was flying and MNKD was still declining.)
In general I agree. However, there are 100 million reasons why we're not the average biotech stock.
I still don't know how the analysts consensus 1st quarter Afrezza saies target could have been $3 - million for less than two months activity.